Abstract
BackgroundIn patients with a first, unprovoked venous thromboembolism (VTE), the optimal duration of anticoagulant therapy (AT) is controversial due to tightly balanced risks and benefits of indefinite anticoagulation. The objective...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have